Page 6 - Al Kildani News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Halozyme to Participate in the 2021 Cantor Virtual Global Healthcare Conference

Halozyme to Participate in the 2021 Cantor Virtual Global Healthcare Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesAl kildaniElaine sunBristol myers squibbCorporate communicationsHalozyme therapeutics incHalozyme therapeuticsVirtual global healthcare conferenceInvestor relationsசான் டியாகோஒன்றுபட்டது மாநிலங்களில்எலைன் சூரியன்பிரிஸ்டல் மைஸ் ஸ்க்விப்ப்பெருநிறுவன தகவல்தொடர்புகள்மெய்நிகர் உலகளாவிய சுகாதாரம் மாநாடு

Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference

Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesCanaccord genuityAl kildaniElaine sunBristol myers squibbHalozyme therapeutics incCorporate communicationsVirtual health care conferencePrnewswire halozyme therapeutics incAnnual growth conference securitiesHealth care conferenceInvestor relationsசான் டியாகோஒன்றுபட்டது மாநிலங்களில்கானக்கோர்ட் உண்மையானது

Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call

Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesAl kildaniHelen torleyBristol myers squibbCorporate communicationsPrnewswire halozyme therapeutics incHalozyme therapeutics incQuarterly update conference callHorizon therapeuticsInvestor relationsசான் டியாகோஒன்றுபட்டது மாநிலங்களில்பிரிஸ்டல் மைஸ் ஸ்க்விப்ப்பெருநிறுவன தகவல்தொடர்புகள்காலாண்டு புதுப்பிப்பு மாநாடு அழைப்பு

Halozyme to Present at Upcoming Investor Conferences

/PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that it will participate at the following investor conferences: The Goldman Sachs.

San diegoUnited statesAl kildaniHelen torleyElaine sunBristol myers squibbCorporate communicationsGoldman sachsPrnewswire halozyme therapeutics incHalozyme therapeutics incSecurities life sciences conference onAnnual global healthcare conferenceLife sciences conferenceInvestor relationsHalozyme therapeuticsசான் டியாகோ

Halozyme Announces Janssen Receives Two Positive CHMP Opinions for DARZALEX® (daratumumab) Subcutaneous Formulation Utilizing ENHANZE®

Halozyme Announces Janssen Receives Two Positive CHMP Opinions for DARZALEX® (daratumumab) Subcutaneous Formulation Utilizing ENHANZE® - For Use of Subcutaneous Daratumumab in Combination with Cyclophosphamide, Bortezomib and Dexamethasone (D-VCd) in Newly Diagnosed Adult Patients with Systemic Light Chain (AL) Amyloidosis - - For Use of Subcutaneous Daratumumab in Combination with Pomalidomide and Dexamethasone (D-Pd) in Adult Patients with Relapsed or Refractory Multiple Myeloma - News provided by Share this article Share this article SAN DIEGO, May 21, 2021 /PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Janssen Pharmaceutica N.V. (Janssen) received two positive opinions from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommending to broaden the existing marketing authorization for the DARZALEX

San diegoUnited statesAl kildaniHelen torleyBristol myers squibbJanssen pharmaceuticaAmerican society of hematology annual meetingEuropean commissionHalozyme therapeutics incExchange commissionCorporate communicationsEuropean medicines agencyCommittee for medicinal products human useEuropean myeloma networkHalozyme therapeuticsMedicinal products